Skip to main content

Published locations for Acalabrutinib yields 95% overall response in relapsed CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Acalabrutinib yields 95% overall response in relapsed CLL

User login

  • Reset your password
  • /content/acalabrutinib-yields-95-overall-response-relapsed-cll
  • /hematologynews/article/106075/cll/acalabrutinib-yields-95-overall-response-relapsed-cll
  • /oncologypractice/article/106075/cll/acalabrutinib-yields-95-overall-response-relapsed-cll
  • /hematology-oncology/article/106075/cll/acalabrutinib-yields-95-overall-response-relapsed-cll
  • /b-cell-lymphoma-icymi/article/106075/cll/acalabrutinib-yields-95-overall-response-relapsed-cll